Search

Mitchell Hill

Examiner (ID: 115)

Most Active Art Unit
3106
Art Unit(s)
2899, 3106
Total Applications
1496
Issued Applications
1329
Pending Applications
6
Abandoned Applications
161

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 558320 [patent_doc_number] => 07157425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders' [patent_app_type] => utility [patent_app_number] => 10/099574 [patent_app_country] => US [patent_app_date] => 2002-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 37034 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157425.pdf [firstpage_image] =>[orig_patent_app_number] => 10099574 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/099574
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Mar 14, 2002 Issued
Array ( [id] => 6721546 [patent_doc_number] => 20030055236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Secreted protein HKABT24' [patent_app_type] => new [patent_app_number] => 10/097065 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112873 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055236.pdf [firstpage_image] =>[orig_patent_app_number] => 10097065 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/097065
Secreted protein HKABT24 Mar 13, 2002 Abandoned
Array ( [id] => 6307847 [patent_doc_number] => 20020094956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Use of alpha1beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease' [patent_app_type] => new [patent_app_number] => 10/099573 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21811 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094956.pdf [firstpage_image] =>[orig_patent_app_number] => 10099573 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/099573
Use of alpha1beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease Mar 11, 2002 Abandoned
Array ( [id] => 5860597 [patent_doc_number] => 20020123846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Method and system for designing proteins and protein backbone configurations' [patent_app_type] => new [patent_app_number] => 10/093108 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4453 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123846.pdf [firstpage_image] =>[orig_patent_app_number] => 10093108 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/093108
Method and system for designing proteins and protein backbone configurations Mar 6, 2002 Abandoned
Array ( [id] => 6553326 [patent_doc_number] => 20020138203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Method and system for designing proteins and protein backbone configurations' [patent_app_type] => new [patent_app_number] => 10/093109 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4446 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20020138203.pdf [firstpage_image] =>[orig_patent_app_number] => 10093109 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/093109
Method and system for designing proteins and protein backbone configurations Mar 6, 2002 Abandoned
Array ( [id] => 6687626 [patent_doc_number] => 20030031350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Methods for large scale protein matching' [patent_app_type] => new [patent_app_number] => 10/087541 [patent_app_country] => US [patent_app_date] => 2002-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5994 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031350.pdf [firstpage_image] =>[orig_patent_app_number] => 10087541 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/087541
Methods for large scale protein matching Feb 28, 2002 Abandoned
10/084615 Platelet production promoting agent Feb 27, 2002 Abandoned
Array ( [id] => 7617002 [patent_doc_number] => 06946439 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments' [patent_app_type] => utility [patent_app_number] => 10/086176 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10841 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946439.pdf [firstpage_image] =>[orig_patent_app_number] => 10086176 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/086176
Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments Feb 27, 2002 Issued
Array ( [id] => 6646757 [patent_doc_number] => 20030104408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method and device for assembling nucleic acid base sequences' [patent_app_type] => new [patent_app_number] => 10/083338 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11387 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104408.pdf [firstpage_image] =>[orig_patent_app_number] => 10083338 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/083338
Method and device for assembling nucleic acid base sequences Feb 26, 2002 Issued
Array ( [id] => 5922900 [patent_doc_number] => 20020115594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Peptide antagonists at glutamate and NMDA receptors' [patent_app_type] => new [patent_app_number] => 10/087011 [patent_app_country] => US [patent_app_date] => 2002-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6964 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115594.pdf [firstpage_image] =>[orig_patent_app_number] => 10087011 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/087011
Peptide antagonists at glutamate and NMDA receptors Feb 25, 2002 Abandoned
Array ( [id] => 6787615 [patent_doc_number] => 20030138854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Method for determining BAGE expression' [patent_app_type] => new [patent_app_number] => 10/081108 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7456 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138854.pdf [firstpage_image] =>[orig_patent_app_number] => 10081108 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/081108
Method for determining BAGE expression Feb 19, 2002 Abandoned
Array ( [id] => 796555 [patent_doc_number] => 07430476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-30 [patent_title] => 'Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity' [patent_app_type] => utility [patent_app_number] => 10/468496 [patent_app_country] => US [patent_app_date] => 2002-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35533 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/430/07430476.pdf [firstpage_image] =>[orig_patent_app_number] => 10468496 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468496
Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity Feb 17, 2002 Issued
Array ( [id] => 6419429 [patent_doc_number] => 20020183937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Method for the generation of proteins with new enzymatic function' [patent_app_type] => new [patent_app_number] => 10/074679 [patent_app_country] => US [patent_app_date] => 2002-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24834 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183937.pdf [firstpage_image] =>[orig_patent_app_number] => 10074679 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/074679
Method for the generation of proteins with new enzymatic function Feb 10, 2002 Abandoned
Array ( [id] => 6844586 [patent_doc_number] => 20030149933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Graphical design of chemical discovery processes' [patent_app_type] => new [patent_app_number] => 10/061960 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8311 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20030149933.pdf [firstpage_image] =>[orig_patent_app_number] => 10061960 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/061960
Graphical design of chemical discovery processes Jan 31, 2002 Abandoned
Array ( [id] => 6048889 [patent_doc_number] => 20020169264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Polymers incorporating peptides' [patent_app_type] => new [patent_app_number] => 10/044034 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16339 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169264.pdf [firstpage_image] =>[orig_patent_app_number] => 10044034 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/044034
Polymers incorporating peptides Jan 10, 2002 Abandoned
Array ( [id] => 6721530 [patent_doc_number] => 20030055220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Protein-protein interactions between Shigella flexneri polypeptides and mammalian polypeptides' [patent_app_type] => new [patent_app_number] => 10/043487 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26996 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055220.pdf [firstpage_image] =>[orig_patent_app_number] => 10043487 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/043487
Protein-protein interactions between Shigella flexneri polypeptides and mammalian polypeptides Jan 10, 2002 Abandoned
Array ( [id] => 6710970 [patent_doc_number] => 20030170719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'NF-kappa B activating gene' [patent_app_type] => new [patent_app_number] => 10/042211 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 20523 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170719.pdf [firstpage_image] =>[orig_patent_app_number] => 10042211 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/042211
NF-kappa B activating gene Jan 6, 2002 Abandoned
Array ( [id] => 6715872 [patent_doc_number] => 20030027220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Chemical modification' [patent_app_type] => new [patent_app_number] => 10/037212 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28325 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027220.pdf [firstpage_image] =>[orig_patent_app_number] => 10037212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/037212
Chemical modification Jan 3, 2002 Abandoned
Array ( [id] => 6730714 [patent_doc_number] => 20030186904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Keratinocyte growth factor-2' [patent_app_type] => new [patent_app_number] => 10/035212 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 144684 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186904.pdf [firstpage_image] =>[orig_patent_app_number] => 10035212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/035212
Keratinocyte growth factor-2 Jan 3, 2002 Abandoned
Array ( [id] => 5908024 [patent_doc_number] => 20020142967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Thrombin inhibitors' [patent_app_type] => new [patent_app_number] => 10/039737 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22385 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142967.pdf [firstpage_image] =>[orig_patent_app_number] => 10039737 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/039737
Thrombin inhibitors Jan 3, 2002 Abandoned
Menu